Revisiting Diagnostic Criteria for Myelodysplastic and Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis: Borderline Cases without Anemia Exist

被引:0
|
作者
Li, Peng [1 ]
Ohgami, Robert S. [2 ]
机构
[1] Univ Florida, Gainesville, FL USA
[2] Stanford Univ, Stanford, CA 94305 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1492
引用
收藏
页码:532 / 532
页数:1
相关论文
共 50 条
  • [41] DNA instability in low-risk myelodysplastic syndromes - refractory anemia with or without ring sideroblasts
    Novotna, B.
    Blazkova, V.
    Neuwirtova, R.
    Siskova, M.
    Bagryantseva, Y.
    LEUKEMIA RESEARCH, 2007, 31 : S72 - S72
  • [42] Retrospective reclassification of Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis based on the 2022 Updated International Consensus Committee: A Single Institute Study
    Bridgelall, Sanjay
    Pakasticali, Nagehan
    Hussaini, Mohammad
    Song, Jinming
    Zhang, Ling
    Tashkandi, Hammad
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1104 - S1105
  • [43] Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis with co-mutated JAK2 and SF3B1
    Reinig, Erica F.
    He, Rong
    BLOOD, 2017, 129 (05) : 656 - 656
  • [45] Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN with RS-T) complicated by hyperleukocytosis and gene analysis in relation to leukocytosis
    Aoyama, Yumi
    Sakai, Kazuko
    Kodaka, Taiichi
    Tsunemine, Hiroko
    Nishio, Kazuto
    Itoh, Tomoo
    Inoue, Daichi
    Takahashi, Takayuki
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2019, 59 (01) : 29 - 33
  • [46] Clinical significance of SF3B1 mutations in Korean patients with myelodysplastic syndromes and myelodysplasia/myeloproliferative neoplasms with ring sideroblasts
    Ja Young Seo
    Ki-O Lee
    Sun-Hee Kim
    Kihyun Kim
    Chul Won Jung
    Jun Ho Jang
    Hee-Jin Kim
    Annals of Hematology, 2014, 93 : 603 - 608
  • [47] Clinical significance of SF3B1 mutations in Korean patients with myelodysplastic syndromes and myelodysplasia/myeloproliferative neoplasms with ring sideroblasts
    Seo, Ja Young
    Lee, Ki-O
    Kim, Sun-Hee
    Kim, Kihyun
    Jung, Chul Won
    Jang, Jun Ho
    Kim, Hee-Jin
    ANNALS OF HEMATOLOGY, 2014, 93 (04) : 603 - 608
  • [48] Concurrent JAK2 V617F and MPL W515L in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
    Ye, Matthew T.
    Wang, Yi
    Wang, Sa A.
    Pemmaraju, Naveen
    Daver, Naval
    Verstovsek, Srdan
    Zhang, Yizhuo
    Zuo, Zhuang
    Medeiros, L. Jeffrey
    You, M. James
    LEUKEMIA & LYMPHOMA, 2020, 61 (04) : 963 - 966
  • [49] A Retrospective Analysis From Patients Treated in The MEDALIST Study: Safety and Efficacy Of Luspatercept Treatment In Patients With Myelodysplastic Syndrome/Myeloproliferative Neoplasm With Ring Sideroblasts And Thrombocytosis
    Komrokji, Rami S.
    Platzbecker, Uwe
    Fenaux, Pierre
    Garcia-Manero, Guillermo
    Mufti, Ghulam J.
    Santini, Valeria
    Diez-Campelo, Maria
    Finelli, Carlo
    Jurcic, Joseph G.
    Greenberg, Peter L.
    Sekeres, Mikkael A.
    Zeidan, Amer M.
    Dezern, Amy E.
    Savona, Michael R.
    Shetty, Jeevan K.
    Ito, Rodrigo
    Zhang, George
    Ha, Xianwei
    Sinsimer, Daniel
    Backstrom, Jay T.
    Verma, Amit
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 67 - 68
  • [50] Clinical Outcomes with Hypomethylating Agents in Patients with Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T); A Case Series
    Siddiqui, Maria Tariq
    Kanagal-Shamanna, Rashmi
    Naqvi, Kiran
    Sasaki, Koji
    Masarova, Lucia
    Jabbour, Elias
    Pemmaraju, Naveen
    Kadia, Tapan M.
    Ravandi, Farhad
    Daver, Naval
    Borthakur, Gautam
    Pierce, Sherry A.
    Verstovsek, Srdan
    Bose, Prithviraj
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Montalban-Bravo, Guillermo
    BLOOD, 2020, 136